10,070
Total Claims
$1.1M
Drug Cost
695
Beneficiaries
$1,605
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-91%
Opioid rate vs peers
0.2% vs 2.2% avg
+14%
Cost per patient vs peers
$1,605 vs $1,411 avg
+12%
Brand preference vs peers
11.9% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
20
Opioid Claims
$46
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
88% generic
Brand: 1,183 claims · $899K
Generic: 8,738 claims · $200K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 63 | $112K |
| Apixaban | 94 | $101K |
| Insulin Glargine,hum.Rec.Anlog | 71 | $59K |
| Semaglutide | 39 | $52K |
| Rivaroxaban | 36 | $49K |
| Liraglutide | 24 | $49K |
| Linagliptin | 34 | $36K |
| Insulin Aspart | 18 | $31K |
| Sitagliptin Phosphate | 32 | $31K |
| Empagliflozin | 25 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 15 | $24K |
| Linaclotide | 30 | $24K |
| Insulin Aspart Prot/Insuln Asp | 12 | $22K |
| Dapagliflozin Propanediol | 17 | $19K |
| Tiotropium Bromide | 13 | $14K |
Prescribing Profile
Patient Profile
74
Avg Age
76%
Female
1.45
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About